QIL1 mutation causes MICOS disassembly and early onset fatal mitochondrial encephalopathy with liver disease
Virginia Guarani,
Claude Jardel,
Dominique Chrétien,
Anne Lombès,
Paule Bénit,
Clémence Labasse,
Emmanuelle Lacène,
Agnès Bourillon,
Apolline Imbard,
Jean-François Benoist,
Imen Dorboz,
Mylène Gilleron,
Eric S Goetzman,
Pauline Gaignard,
Abdelhamid Slama,
Monique Elmaleh-Bergès,
Norma B Romero,
Pierre Rustin,
Hélène Ogier de Baulny,
Joao A Paulo,
J Wade Harper,
Manuel Schiff
Affiliations
Virginia Guarani
Department of Cell Biology, Harvard Medical School, Boston, United States
Claude Jardel
Inserm U1016, Institut Cochin, CNRS UMR 8104, Paris, France; Department of Biochemistry, APHP, GHU Pitié-Salpêtrière, Paris, France; Université Paris-Descartes, Paris, France
Dominique Chrétien
UMR1141, PROTECT, INSERM, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France
Anne Lombès
Inserm U1016, Institut Cochin, CNRS UMR 8104, Paris, France; Department of Biochemistry, APHP, GHU Pitié-Salpêtrière, Paris, France; Université Paris-Descartes, Paris, France
Paule Bénit
UMR1141, PROTECT, INSERM, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France
Clémence Labasse
Neuromuscular morphology unit, Institut de Myologie, GHU Pitié-Salpêtrière, APHP, Paris, France
Emmanuelle Lacène
Neuromuscular morphology unit, Institut de Myologie, GHU Pitié-Salpêtrière, APHP, Paris, France
Agnès Bourillon
Department of Biochemistry, Hôpital Robert Debré, APHP, Paris, France
Apolline Imbard
Department of Biochemistry, Hôpital Robert Debré, APHP, Paris, France
Jean-François Benoist
Department of Biochemistry, Hôpital Robert Debré, APHP, Paris, France
Imen Dorboz
UMR1141, PROTECT, INSERM, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France
Mylène Gilleron
Inserm U1016, Institut Cochin, CNRS UMR 8104, Paris, France; Department of Biochemistry, APHP, GHU Pitié-Salpêtrière, Paris, France; Université Paris-Descartes, Paris, France
Eric S Goetzman
Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, United States; University of Pittsburgh, Pittsburgh, United States; Children's Hospital of Pittsburgh of UPMC, Pittsburgh, United States
Pauline Gaignard
Department of Biochemistry, Hôpital Bicêtre, APHP, Paris, France
Abdelhamid Slama
Department of Biochemistry, Hôpital Bicêtre, APHP, Paris, France
Monique Elmaleh-Bergès
Department of Radiology, Hôpital Robert Debré, APHP, Paris, France
Norma B Romero
Neuromuscular morphology unit, Institut de Myologie, GHU Pitié-Salpêtrière, APHP, Paris, France
Pierre Rustin
UMR1141, PROTECT, INSERM, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France
Hélène Ogier de Baulny
Reference Center for Inborn Errors of Metabolism, Robert Debré University Hospital, APHP, Paris, France
Joao A Paulo
Department of Cell Biology, Harvard Medical School, Boston, United States
Department of Cell Biology, Harvard Medical School, Boston, United States
Manuel Schiff
UMR1141, PROTECT, INSERM, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Reference Center for Inborn Errors of Metabolism, Robert Debré University Hospital, APHP, Paris, France
Previously, we identified QIL1 as a subunit of mitochondrial contact site (MICOS) complex and demonstrated a role for QIL1 in MICOS assembly, mitochondrial respiration, and cristae formation critical for mitochondrial architecture (Guarani et al., 2015). Here, we identify QIL1 null alleles in two siblings displaying multiple clinical symptoms of early-onset fatal mitochondrial encephalopathy with liver disease, including defects in respiratory chain function in patient muscle. QIL1 absence in patients’ fibroblasts was associated with MICOS disassembly, abnormal cristae, mild cytochrome c oxidase defect, and sensitivity to glucose withdrawal. QIL1 expression rescued cristae defects, and promoted re-accumulation of MICOS subunits to facilitate MICOS assembly. MICOS assembly and cristae morphology were not efficiently rescued by over-expression of other MICOS subunits in patient fibroblasts. Taken together, these data provide the first evidence of altered MICOS assembly linked with a human mitochondrial disease and confirm a central role for QIL1 in stable MICOS complex formation.